Skip to main content

Advertisement

ADVERTISEMENT

News

Nanoparticle Therapies
04/18/2024

Washington University in St. Louis News

Washington University in St. Louis Ne...
With a four-year, $2.07 million grant from the NIH, researchers plan to enclose a set of proteins designed to curb inflammation and a peptide to prevent fibrosis inside cleverly disguised drug-delivering smart nanoparticles. These...
With a four-year, $2.07 million grant from the NIH, researchers plan to enclose a set of proteins designed to curb inflammation and a peptide to prevent fibrosis inside cleverly disguised drug-delivering smart nanoparticles. These...
With a four-year, $2.07 million...
04/18/2024
Cath Lab Digest

Advertisement

TAVR
04/17/2024

Caranx Medical News

Caranx Medical News
“The team at Caranx has achieved an important milestone as it successfully deployed a balloon-expandable device in the aortic position, in a pig model. This extremely promising step paves the way to a first-in-human utilization," says Dr....
“The team at Caranx has achieved an important milestone as it successfully deployed a balloon-expandable device in the aortic position, in a pig model. This extremely promising step paves the way to a first-in-human utilization," says Dr....
“The team at Caranx has achieved...
04/17/2024
Cath Lab Digest
Intravascular Lithotripsy
04/16/2024

FastWave Medical Inc. News

FastWave Medical Inc. News
"FastWave's novel approach has enormous potential to leapfrog today's IVL technology with durable, fast, and consistent laser energy," says Dr. William Nicholson. "It also enables FastWave's team of engineers to develop an ultra-sleek balloon...
"FastWave's novel approach has enormous potential to leapfrog today's IVL technology with durable, fast, and consistent laser energy," says Dr. William Nicholson. "It also enables FastWave's team of engineers to develop an ultra-sleek balloon...
"FastWave's novel approach has...
04/16/2024
Cath Lab Digest
PerQseal Elite Vascular Closure System
Venous Closure
04/15/2024

Vivasure Medical News

Vivasure Medical News
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, announced it has treated the first large bore venous patient with the PerQseal® Elite vascular closure system, a sutureless and fully...
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, announced it has treated the first large bore venous patient with the PerQseal® Elite vascular closure system, a sutureless and fully...
Vivasure Medical, a company...
04/15/2024
Cath Lab Digest

Advertisement

Wrist-based monitoring
04/11/2024

Verily News

Verily News
A study conducted by Verily, Duke University, and Stanford University demonstrates that the walking behavior captured by Verily Study Watch, a wrist-worn device designed for research purposes, is associated with different levels of heart...
A study conducted by Verily, Duke University, and Stanford University demonstrates that the walking behavior captured by Verily Study Watch, a wrist-worn device designed for research purposes, is associated with different levels of heart...
A study conducted by Verily,...
04/11/2024
Cath Lab Digest
Tricuspid Valve Treatment
04/11/2024

Minneapolis Heart Institute Foundation® News

Minneapolis Heart Institute Foundatio...
Minneapolis Heart Institute Foundation® (MHIF) announced the first enrollment in the VISTA U.S. early feasibility study offering a new transcatheter tricuspid valve technology for severe tricuspid valve regurgitation. Paul Sorajja, MD,...
Minneapolis Heart Institute Foundation® (MHIF) announced the first enrollment in the VISTA U.S. early feasibility study offering a new transcatheter tricuspid valve technology for severe tricuspid valve regurgitation. Paul Sorajja, MD,...
Minneapolis Heart Institute...
04/11/2024
Cath Lab Digest
Lower-extremity intervention
04/10/2024

Brigham and Women's Hospital / Boston Medical Center News

Brigham and Women's Hospital / Boston...
“Our study indicates that patients with CLTI have a notably poor quality of life – substantially lower than with many other chronic conditions,” said Matthew Menard, MD. “Our findings show that revascularization significantly improves quality...
“Our study indicates that patients with CLTI have a notably poor quality of life – substantially lower than with many other chronic conditions,” said Matthew Menard, MD. “Our findings show that revascularization significantly improves quality...
“Our study indicates that...
04/10/2024
Cath Lab Digest

Advertisement

Drug Safety
04/10/2024

American Physiological Society (APS) News

American Physiological Society (APS) ...
“We found that regular use of acetaminophen at concentrations that are considered safe—equivalent to 500 mg/day—causes numerous signaling pathways inside the heart to be altered,” said Gabriela Rivera, the study’s first author. “These results...
“We found that regular use of acetaminophen at concentrations that are considered safe—equivalent to 500 mg/day—causes numerous signaling pathways inside the heart to be altered,” said Gabriela Rivera, the study’s first author. “These results...
“We found that regular use of...
04/10/2024
Cath Lab Digest
Triglycerides
04/10/2024

American College of Cardiology Scientific Sessions News

American College of Cardiology Scient...
“Treatments to reduce high triglycerides are an unmet clinical need,” said Brian Bergmark, MD, the study’s principal investigator. “Based on our study’s results, we can say that the drug worked and appeared to be safe. We tested two doses of...
“Treatments to reduce high triglycerides are an unmet clinical need,” said Brian Bergmark, MD, the study’s principal investigator. “Based on our study’s results, we can say that the drug worked and appeared to be safe. We tested two doses of...
“Treatments to reduce high...
04/10/2024
Cath Lab Digest
Mechanical Circulatory Support
04/10/2024

International Society for Heart and Lung Transplantation News

International Society for Heart and L...
“In the next five years, new pumps will have a fully internalized power line and be wirelessly powered from outside the body, just like our iPhones,” said Mandeep R. Mehra, MD, of the Center for Advanced Heart Disease at Brigham Health....
“In the next five years, new pumps will have a fully internalized power line and be wirelessly powered from outside the body, just like our iPhones,” said Mandeep R. Mehra, MD, of the Center for Advanced Heart Disease at Brigham Health....
“In the next five years, new...
04/10/2024
Cath Lab Digest

Advertisement

Advertisement